RICHMOND, BRITISH COLUMBIA — (Marketwire) — 02/29/12 — Yaletown Capital Corp. (“Yaletown”, the “Company”) (TSX VENTURE: YCC) announces that as a result of a review by the B.C. Securities Commission, we are issuing the following press release to clarify our disclosure as required by Part 11.5 of NI 51-102.
The Company has re-filed its interim financial report which was initially filed for the period ended September 30, 2011 and was deemed as deficient and non-compliant with IFRS 1 and IAS 34 requirements. The condensed consolidated financial statements and accompanying notes required restatement and the management discussion and analysis was revised to reflect the restated financial report.
The Company anticipates that the Executive Director of the B.C. Securities Commission will make an order under Section 164 of the BC Securities Act and rules to revoke its previous order of February 2nd, 2012 whereby the Company-s securities ceased trading.
About Yaletown Capital Corporation and its wholly owned subsidiary, Freedom
Bionics:
Yaletown Capital Corporation and its subsidiary, Freedom Bionics, specialise in the design of network-based safety, communications and cognitive assistance applications, products and services. Yaletown Capital Corporation is listed on the TSX-Venture Exchange under the symbol “YCC”. Information on the Company-s new products is available on
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Yaletown Capital Corp.
Douglas Kind
President & CEO
(604) 242-9000
You must be logged in to post a comment Login